openPR Logo
Press release

Extracellular Matrix Market is expected to Cross US$ 47.46 Million by 2027 Globally, Says The Insight Partners | COOK BIOTECH, Medtronic, Aziyo Biologics, DSM Biomedical

07-15-2019 10:43 PM CET | Health & Medicine

Press release from: The Insight Partners

Extracellular Matrix market

Extracellular Matrix market

The potential of regenerative medicine that facilitates tissue regeneration in the affected area reduced the requirement of tissue transplant. The extracellular matrix is derived from a readily available tissue source, it can stimulate the growth of tissue in vivo with minimal inflammation, and it is available off the shelf. These advantages of the extracellular matrix enables in the ideal soft tissue replacement treatment procedures to repair contour defects.

Therefore, there is increase in the vascular reconstruction or the plastic surgeries are anticipated to grow the extracellular matrix during the forecast period. According to the American Society of Plastic Surgeons (ASPS) states that in 2018, across US approximately 17.7 million surgical and minimally invasive aesthetic procedures were performed. This accounts nearly 277,000 more cosmetic procedures performed in 2017. In addition, nearly 2.68 million procedures were performed for soft tissue repair fillers and this surgery has grown by 2% from 2017. Thus, owing to the above mentioned factors the market is likely to propel during the forecast period.

Get Sample Copy of the Report at - http://tiny.cc/2per9y

The global extracellular matrix market accounted to US$ 24.30 Mn in 2018 and is expected to grow at a CAGR of 8.2% during the forecast period 2019 – 2027, to account to US$ 47.46Mn by 2027.

Company Profiles Includes:

- Admedus
- Coloplast Group
- Merck KGaA
- Smith & Nephew
- MTF Biologics
- Lattice Biologics Ltd.
- COOK BIOTECH, INC.
- Medtronic
- Aziyo Biologics, Inc.
- DSM Biomedical

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the medical devices. The growth is driven by that countries such as China, Japan, and India which are engaged in conducting several studies. For instance, Australia is also involved in the several studies and also it has held various conferences for the tissue engineering and other application of the extracellular matrix.

Market Insights

Increasing Vascular Reconstruction Procedures
The potential of regenerative medicine that facilitates tissue regeneration in the affected area reduced the requirement of tissue transplant. The extracellular matrix is derived from a readily available tissue source, it can stimulate the growth of tissue in vivo with minimal inflammation, and it is available off the shelf. These advantages of the extracellular matrix enables in the ideal soft tissue replacement treatment procedures to repair contour defects.

Therefore, there is increase in the vascular reconstruction or the plastic surgeries are anticipated to grow the extracellular matrix during the forecast period. According to the American Society of Plastic Surgeons (ASPS) states that in 2018, across US approximately 17.7 million surgical and minimally invasive aesthetic procedures were performed. This accounts nearly 277,000 more cosmetic procedures performed in 2017. In addition, nearly 2.68 million procedures were performed for soft tissue repair fillers and this surgery has grown by 2% from 2017. Thus, owing to the above mentioned factors the market is likely to propel during the forecast period.

Opportunities To Treat Cancer

The studies for the molecular cell biology of extracellular matrix (ECM) are being conducted across the world. The cell adhesion molecules (CAMs), other properties and advantages of the extracellular matrix are turning out to be beneficial area of discovery with several interesting factors for disease and disorders in animals and humans. These advantages are also include treating of some cancers such as breast cancer, pancreatic cancer, liver cancer and colon cancer.

In addition, obesity is coupled with increasing severity of diagnoses for several types of cancer. Also there have been collective evidences that have shown mechanism that enables obese cells or tissue to serve as an extracellular matrix for the cancer progression. However, extracellular matrix holds vital responsibilities in facilitating the proper development and homeostasis of tissues. The extracellular matrix can also govern both normal and cancer cell function and fate.

For instance, studies have proven that extracellular matrix isolated from virgin rat mammary glands has been shown to exert antitumorigenic effects on breast cancer cells. Also extracellular matrix isolated from involuting rat mammary glands inhibits the growth of tumorous cells. On the other hand, the protumorigenic effects of the latter are mediated by a mechanism of inflammatory signaling that can be inhibited by nonsteroidal anti-inflammatory drugs.

Avail Discount on the Report at - http://tiny.cc/hper9y

Raw Material Insights

The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the growth of the extracellular matrix market.

Strategic Insights

Organic and inorganic growth strategies were observed in global extracellular matrix industry. The organic strategies which were conducted more compared to the inorganic strategies for the extracellular matrix. For instance, in March, 2019, MTF Biologics launched CartiMax Viable Cartilage, for easily filling the lesions in the knee, foot and ankle. The launch demonstrates stable viability post-cryopreservation and provides the clinical benefits of, viable cartilage matrix with live cells. Thus, the organic strategy has enabled the company to grow its business in the market.

Extracellular Matrix – MARKET SEGMENTATION

By Application

• Vascular Repair and Reconstruction
• Dural Repair
• Wound Healing
• Cardiac Repair
• Pericardial Repair
• Soft Tissue Repair

By Raw Material

• Bovine
• Porcine
• Others

Purchase this report at - http://tiny.cc/ioer9y

Key Reasons to buy this report:

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Extracellular Matrix Market.

- Highlights key business priorities in order to assist companies to realign their business strategies.

- The key findings and recommendations highlight crucial progressive industry trends in the Extracellular Matrix, thereby allowing players to develop effective long term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Extracellular Matrix Market is expected to Cross US$ 47.46 Million by 2027 Globally, Says The Insight Partners | COOK BIOTECH, Medtronic, Aziyo Biologics, DSM Biomedical here

News-ID: 1804482 • Views:

More Releases from The Insight Partners

Denim Fabrics Market by Demand Analysis, Manufacturers Share, Regions, Risk Analysis, Driving Forces and Application, Forecast to 2031
Denim Fabrics Market by Demand Analysis, Manufacturers Share, Regions, Risk Anal …
The Insight Partners adds "Denim Fabrics Market Forecast to 2031 COVID-19 Impact and Global Analysis" to its store providing analysis of the current and future market competition in the market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00018240?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: SANKO Holding Candiani S.p.A. Hyde Park Denim Cone Denim LLC KG DENIM LIMITED Zeva Denim Prosperity Textile T?SA AtlasDenim Arvind Limited The
Split Air Conditioning Market Set for Strong Growth Driven by Energy Efficiency and Smart Home Integration Trends
Split Air Conditioning Market Set for Strong Growth Driven by Energy Efficiency …
New York, US - October 27, 2025 - According to a new report published by The Insight Partners, the Split Air Conditioning Market is projected to witness steady growth from 2025 to 2031, registering a CAGR of XX%. The market size is expected to expand from US$ XX Million in 2024 to US$ XX Million by 2031, fueled by increasing consumer demand for energy-efficient, eco-friendly, and technologically advanced air conditioning
Intelligent Pipeline Pigging Market Projected for 6.3% CAGR Growth During 2025-2031 Forecast Period
Intelligent Pipeline Pigging Market Projected for 6.3% CAGR Growth During 2025-2 …
New York, US - October 27, 2025 - The Intelligent Pipeline Pigging Market is poised for steady expansion, reaching US$ 1,244.2 million by 2031, up from US$ 782.3 million in 2023, registering a CAGR of 6.3% from 2025 to 2031. This strong trajectory highlights the growing importance of advanced pigging solutions that enhance pipeline integrity, operational efficiency, and environmental safety. As global energy and utility networks continue to expand, the demand
Biopharmaceutical Tubing Market to Reach US$ 7.64 Billion by 2031, Growing at 8.3% CAGR
Biopharmaceutical Tubing Market to Reach US$ 7.64 Billion by 2031, Growing at 8. …
The Insight Partners is proud to announce its latest report, "Biopharmaceutical Tubing Market - Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2031." The report provides a comprehensive analysis of the Biopharmaceutical Tubing Market, covering market trends, growth dynamics, technological advancements, and competitive developments shaping the future of bioprocessing and pharmaceutical manufacturing. Check valuable insights in the Biopharmaceutical Tubing Market report. You can easily get a sample PDF of the

All 5 Releases


More Releases for Extracellular

Extracellular Matrix Top Companies Data 2021 to 2028
The extracellular matrix market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004925/?utm_source=OpenPR&utm_medium=10413 The List of Companies - Extracellular Matrix • Anteris • Aziyo Biologics, Inc • Coloplast Group • Cook Biotech, Inc • DSM Biomedical • Baxter • Medtronic • Merck KGaA • MTF Biologics • Smith & Nephew Conatct US: If you have any queries about this report or if you would like further information, please Contact Person:
Extracellular Matrix Market Global Rising Demand & Huge Scope Till 2028
Extracellular Matrix Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Extracellular Matrix Market Survey Report on Industry Opportunities and Threats
Global Extracellular Matrix Market Report is a professional and in-depth survey on the current state of the Extracellular Matrix Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Extracellular Matrix Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00004925?utm_source=OpenPR&utm_medium=10867 Key Players Analysis: Anteris Aziyo Biologics, Inc Coloplast Group Cook Biotech, Inc DSM
Extracellular Polymeric Substances Market, Global Outlook and Forecast 2024-2030
𝐆𝐥𝐨𝐛𝐚𝐥 𝐄𝐱𝐭𝐫𝐚𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫 𝐏𝐨𝐥𝐲𝐦𝐞𝐫𝐢𝐜 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟗𝟕𝟖.𝟑𝟔 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟕𝟎% 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟐𝟎𝟐𝟑 𝐭𝐨 𝟐𝟎𝟑𝟎. The USA market for Global Extracellular Polymeric Substances market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.24chemicalresearch.com/download-sample/250908/global-extracellular-polymeric-substances-forecast-market-2024-2030-600 The
North America Extracellular Matrix Market Size and Share Insights 2021
The North America extracellular matrix market is expected to reach US$ 20,111.6 Thousands by 2028 from US$ 12,163.1 Thousands in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021-2028. The Business Market Insights North America Extracellular Matrix Market report 2028, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The North America Extracellular Matrix
Extracellular Matrix market rising at 7.6 % CAGR to 2028
The proposed Extracellular Matrix market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The extracellular matrix market is projected to reach US$ 52.72